1970
DOI: 10.1172/jci106212
|View full text |Cite
|
Sign up to set email alerts
|

Glycogenesis and glyconeogenesis in human platelets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1971
1971
1986
1986

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…At this time, therefore, we are not able to suggest the nature of the "storage lesion." In all in vitro systems described to date (17,29), platelet glycogen is depleted as time passes. Karpatkin, Charmatz, and Langer (29) have also observed that glycogen levels fall more rapidly when platelets are concentrated; no explanation for this phenomenon is apparent.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…At this time, therefore, we are not able to suggest the nature of the "storage lesion." In all in vitro systems described to date (17,29), platelet glycogen is depleted as time passes. Karpatkin, Charmatz, and Langer (29) have also observed that glycogen levels fall more rapidly when platelets are concentrated; no explanation for this phenomenon is apparent.…”
Section: Discussionmentioning
confidence: 99%
“…In all in vitro systems described to date (17,29), platelet glycogen is depleted as time passes. Karpatkin, Charmatz, and Langer (29) have also observed that glycogen levels fall more rapidly when platelets are concentrated; no explanation for this phenomenon is apparent. The cell possesses the capacity to maintain ATP levels, to utilize extracellular glucose, and to increase glucose utilization dramatically when stimulated as shown by the incubations in the presence of NaCN.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Karpatkin and Langer (770,771) have demonstrated that inactive phosphorylase species exist in platelets (both monomeric and dimeric) and that these can be activated by treatment with ATP-Mg2+. Deficiencies of phosphorylase kinase in liver (766) and liver tumor (767) associated with increased deposition of glycogen and low phosphorylase activity have been reported.…”
Section: Phosphorylases Of Blood Cells and Genetic Disorders Of Phospmentioning
confidence: 99%